CATX Johan M Spoor buys $59K worth of shares
Apr 02, 2025, 4:33 AM
0.00%
What does CATX do
Perspective Therapeutics, based in Seattle, is a biotechnology company focused on developing radiopharmaceuticals for cancer treatment using the alpha-emitting isotope 212Pb. Their programs for melanoma and neuroendocrine tumors are in Phase I/IIa trials.
Johan M Spoor bought 26,676 shares of CATX on 28 March at $2.21 per share, worth a total of $59K. They now own 59,383 CATX shares, or a 82% holding increase.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.